Company / SG&A per Share
Zai Lab Ltd SG&A per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.26
FY2025
5-year range
$0.12 / $0.80
FY2021-FY2025
Trend
-16.2%
vs FY2024
Sector context
#193 of 210
Health Care
What the data says
Among 210 Health Care companies, Zai Lab Ltd is in the top 8% for sg&a per share. SG&A per Share has fluctuated over the past 8 years, ranging from $0.12 in FY2022 to $1.09 in FY2019.
Based on SEC 10-K filings.
0.26 in FY2025 with a 5-year CAGR of -4.0%.
Improved from $0.29 to $0.26 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +30.3%
- 5-Year CAGR
- -4.0%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 210This company $0.26 Sector average $40.75
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 16.2% year-over-year.
- Ranks #193 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.26 | -16.2% |
| FY2024 | $0.31 | +4.8% |
| FY2023 | $0.29 | +151.6% |
| FY2022 | $0.12 | -85.4% |
| FY2021 | $0.80 | +152.9% |
| FY2020 | $0.32 | -71.0% |
| FY2019 | $1.09 | +166.0% |
| FY2018 | $0.41 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026